← Open Payments lookup

AMANDA THOMAS: Open Payments

NPI 1326464769 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,352 in 59 payments from 16 companies in 2025. Trend: 2023 $834 · 2024 $941 · 2025 $1,352

Food & beverage: $1,352
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$344
Regeneron Healthcare Solutions, Inc.17$257
BioCryst US Sales Co., LLC7$167
Takeda Pharmaceuticals U.S.A., Inc.8$163
GlaxoSmithKline, LLC.3$68
CSL Behring2$64
Novartis Pharmaceuticals Corporation3$53
GENZYME CORPORATION2$48
Optinose US, Inc.2$43
PFIZER INC.2$37

Products named: DUPIXENT, FASENRA, ORLADEYO, CUVITRU, TRELEGY ELLIPTA, Xhance, OCTAGAM IMMUNE GLOBULIN (HUMAN), XOLAIR.

Industry payments across TX — which companies pay providers there.